Chris Stevens

Chris Stevens Email and Phone Number

Clinical Development Consultant to the Biopharmaceutical Industry @ ClearB Therapeutics
Chris Stevens's Location
Greater Boston, United States, United States
Chris Stevens's Contact Details

Chris Stevens work email

Chris Stevens personal email

About Chris Stevens

Chief Medical Officer at Artugen, Bacainn, and ClearB TherapeuticsGastroenterologist with 17 years of academic experience at Beth Israel Deaconess Medical Center in Boston and faculty member Harvard Medical School. The past 22 years working in pharmaceutical and biotechnology industry with experience in gastroenterology, hepatology, immunology and inflammation.Specialties: Independent consultant 16 of past 22 years specializing in gastrointestinal diseases with an emphasis on clinical development from first in human studies to regulatory approval in inflammatory, infectious and rare disease indications including inflammatory bowel disease, C. difficile colitis, hepatitis B, and hereditary angioedema.

Chris Stevens's Current Company Details
ClearB Therapeutics

Clearb Therapeutics

View
Clinical Development Consultant to the Biopharmaceutical Industry
Chris Stevens Work Experience Details
  • Clearb Therapeutics
    Chief Medical Officer
    Clearb Therapeutics May 2019 - Present
    Greater Boston Area, Ma, Us
  • Photuris
    President
    Photuris Jun 2004 - Present
    Sheffield, Yorkshire, Gb
    Independent consultant for the biopharmaceutical industry in the areas of gastroenterology, hepatology, immunology, rare disease and inflammation
  • Astria Therapeutics, Inc.
    Interim Chief Medical Officer
    Astria Therapeutics, Inc. Oct 2021 - Aug 2022
    Boston, Ma, Us
  • Bacainn
    Chief Medical Officer
    Bacainn Jan 2019 - Jan 2022
  • Artugen
    Chief Medical Officer
    Artugen Jan 2019 - Jan 2022
  • Arsanis, Inc.
    Chief Medical Officer
    Arsanis, Inc. Jun 2016 - Jan 2019
    Arsanis developed a monoclonal antibody combination product targeting Staphylococcus aureus toxins from IND filing through to Phase 2 for the prevention of Staphylococcus aureus pneumonia in mechanically ventilated patients.
  • Forum Pharmaceuticals
    Consultant
    Forum Pharmaceuticals Jul 2013 - May 2016
    Us
    Gastroenterology expert as needed for clinical trial activities
  • Dyax Corp
    Consultant
    Dyax Corp Oct 2011 - Mar 2016
    Burlington, Ma, Us
    Senior Advisor for drug development and medical affairs activities reporting to the CMO
  • Takeda Millenium
    Consultant
    Takeda Millenium Jul 2012 - Dec 2013
    Gastrointestinal expert on team with BLA filing for vedolizumab with FDA and EMA including fast track application with FDA, and participation with Sponsor at the Scientific Advisory Panel Meeting at FDA. Vedolizumab was ultimately approved for the treatment of both Crohn's disease and ulcerative colitis indications in both the United States and Europe.
  • Biomodels
    Consultant For Inflammatory Bowel Disease Animal Models
    Biomodels 2006 - Apr 2012
    Assisted Biomodels establishing relevant inflammatory bowel disease rodent models incorporating animal endoscopy as an outcome demonstrating endoscopic scores of colitis correlated with the extent of histopathological disease in these models.
  • Rhythm
    Consultant
    Rhythm Nov 2010 - Feb 2012
    Physician on team assisting with clinical sections of IND filing that was accepted by the FDA and designing Phase 1 clinical trials for a small molecule indicated for the treatment of obesity
  • Cubist Pharmaceuticals
    Consultant
    Cubist Pharmaceuticals 2006 - 2012
    Lexington, Ma, Us
    Functioned as medical director on surotomycin program discovered at Cubist for the treatment of C. difficile infection from IND through end of Phase 2
  • Eli Lilly And Company
    Consultant
    Eli Lilly And Company Jun 2010 - Jan 2011
    Indianapolis, Indiana, Us
    Eli Lilly acquired Alnara in 2010 and I was retained by Lilly as a consultant through a transition period
  • Alnara Pharmaceuticals
    Senior Vice President Clinical Development
    Alnara Pharmaceuticals Mar 2009 - Jan 2011
    Responsible for building clinical team completing 2 safety trials and leading clinical activities that led to the successful NDA filing for Alnara's lead candidate liprotamase indicated for the treatment of exocrine pancreatic insufficiency. Presented at the FDA Gastrointestinal advisory panel for liprotamase
  • Genzyme
    Consultant
    Genzyme 2007 - 2009
    Paris, France, Fr
    I was the gastroenterology expert on a team investigating in-licensing opportunities for products with gastrointestinal indications
  • Beth Israel Deaconess Medical Center
    Gastroenterologist
    Beth Israel Deaconess Medical Center Aug 1988 - Apr 2007
    Boston, Ma, Us
    Physician scientist with a clinical focus on the care of patients with inflammatory bowel disease and research interest in the pathobiology of the intestinal mucosal inflammation of Crohns disease and ulcerative colitis
  • Ucb
    Gastroenterology Consultant
    Ucb 2006 - 2007
    Brussels, Be
    Gastroenterology expert on the team responding to questions from EMA for the filing of certolizumab for the treatment of Crohn's disease
  • Biogen Idec
    Consultant Gastroenterology
    Biogen Idec 2006 - 2006
    Assisted development team with clinical trial designs for Phase 2 ulcerative colitis studies
  • Altus Pharmaceuticals
    Medical Director
    Altus Pharmaceuticals 2001 - 2004
    Wrote clinical sections of IND, designed and implemented three Phase I clinical trials and designed the phase 2 trial for liprotamase indicated for the treatment of exocrine pancreatic insufficiency
  • Circe Biomedical
    Medical Director
    Circe Biomedical 1998 - 2000
    Involved in all medical aspects of the company including clinical development, clinical operations, fund raising, alliance management, and ultimately sale of the company
  • Harvard Medical School
    Assistant Professor Of Medicine
    Harvard Medical School 1993 - 1998
    Boston, Ma, Us
    NIH funded physician scientist investigating the role of mucosal inflammatory mediators in inflammatory bowel diseases

Chris Stevens Skills

Clinical Development Immunology Gastroenterology Clinical Research Hepatology Biopharmaceuticals Animal Models Clinical Trials Biotechnology Pharmaceutical Industry Lifesciences Oncology Drug Development Infectious Diseases Ctms Fda Ind Medical Affairs Medicine Life Sciences Inflammation Clinical Trial Management System U.s. Food And Drug Administration

Chris Stevens Education Details

  • University Of Miami Miller School Of Medicine
    University Of Miami Miller School Of Medicine
    Medicine
  • University Of North Carolina At Chapel Hill
    University Of North Carolina At Chapel Hill
    Chemistry

Frequently Asked Questions about Chris Stevens

What company does Chris Stevens work for?

Chris Stevens works for Clearb Therapeutics

What is Chris Stevens's role at the current company?

Chris Stevens's current role is Clinical Development Consultant to the Biopharmaceutical Industry.

What is Chris Stevens's email address?

Chris Stevens's email address is ac****@****ail.com

What schools did Chris Stevens attend?

Chris Stevens attended University Of Miami Miller School Of Medicine, University Of North Carolina At Chapel Hill.

What are some of Chris Stevens's interests?

Chris Stevens has interest in Economic Empowerment, Education, Environment, Poverty Alleviation, Science And Technology, Human Rights, Health.

What skills is Chris Stevens known for?

Chris Stevens has skills like Clinical Development, Immunology, Gastroenterology, Clinical Research, Hepatology, Biopharmaceuticals, Animal Models, Clinical Trials, Biotechnology, Pharmaceutical Industry, Lifesciences, Oncology.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.